US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jul 30, 2025 (13 months ago)

4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.

What was recalled

4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)

Recalling firm
Exela Pharma Sciences LLC
NDC code
51754-5012-1
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0620-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Bicarbonate recalls

See all